ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Thidiazuron outpaces 6-benzylamino purine and kinetin in delaying flower senescence in Gladiolus grandiflora by alleviating physiological and biochemical responses

Madhulika Singh, Neha Tiwari.



Abstract
Download PDF Cited by 2 ArticlesPost

An experiment was carried out to elucidate the role of thidiazuron (TDZ), 6-benzylamino purine (BAP), and kinetin on the vase life of Gladiolus grandiflora cut flower. Harvested flowers were treated with BAP, kinetin, and TDZ of various concentrations, viz., 100 µM, 0.5 mM, and 1 mM. Our findings revealed that there was a significant increase in flower longevity in treatment with BAP, kinetin, and TDZ as compared to untreated flowers. Vase solutions which contain BAP (0.5 mM), kinetin (1 mM), and TDZ (100 µM) were most effective in improving vase life (14, 13, and 15 days, respectively) of cut Gladiolus floral spike. Flower vase life was extended with increase in fresh weight, vase solution uptake, high membrane integrity, besides reduced pH of vase solution, malondialdehyde content, and lipoxygenase activity in the flowers. However, TDZ outpaced BAP and kinetin in improving the vase life of G. grandiflora.

Key words: Gladiolus grandiflora, lipid peroxidation, lipoxygenase, membrane stability index, Senescence, vase life







Bibliomed Article Statistics

38
41
47
50
28
25
20
33
33
32
36
23
R
E
A
D
S

13

13

51

14

15

13

11

17

19

13

26

21
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.